Page 160 - Read Online
P. 160

Shaikhrezai et al.                                                                                                                                                                     Late presenting valve endocarditis

           the valve orifice is uncommon. Pannus formation was   may have a role in the mechanical valves of the future
           the causes mechanical valve obstruction in about 10%   despite  the  findings  of  the  recently  published  RE-
           of valves. [3]                                     ALIGN trial. [10]  It may be a reality to have alternatives
                                                              to coumadin therapy for mechanical valves in the near
           Implantation of prosthetic valve in tricuspid position   future.
           has  been  debated  frequently  in  the  literature  with  a
           consensus  on bioprosthesis  favouring mechanical   DECLARATIONS
           valve due to the increased occurrence of valve-related
           events, especially the composite of thrombosis,    Authors’ contributions
           embolism, and bleeding high risk of thrombosis when   Writing manuscript, operating surgeon: K. Shaikhrezai
           a mechanical valve is implanted in tricuspid position. [4,5]    Writing and reviewing manuscript: S.S.A. Singh
           The management of thrombosis can be challenging and
           depending on patient clinical manifestation or degree   Reviewing manuscript: C. Spadaccio
                                                              Supervision and operating surgeon: S. Hunter
           of valvular obstruction the management can vary from
           observation to emergency operation. [6]
                                                              Financial support and sponsorship
           With  the  emergence  of  transcatheter  technology,   None.
           bioprosthetic valve implantation in the tricuspid position
           is an ideal alternative while future valve-in-valve   Conflicts of interest
           implantation feasible in the event of valve failure.    There are no conflicts of interest.
                                                          [7]
           To our knowledge there is no report of mechanical
           valve implantation lasting more than 30 years in the   Patient consent
           tricuspid position.  The abovementioned patient  had   Written consent  was obtained from the patient
           excellent compliance with anticoagulation therapy,   preoperatively.
           thus explaining his mechanical valve longevity without
           any episodes of thrombosis. It has been observed that   Ethics approval
           non-compliance with coumadin plays a pivotal role in   Medical Photography was obtained with permission
           thrombosis and valve malfunction. [4]              from the patient and the Local Clinical Governance
                                                              Committee.
           Bjork-Shiley tilting disc valves had a good clinical
           profile  following  decades  of  implantation.  However,   REFERENCES
           they became obsolete following the invention of more
           innovative  mechanical  valves  with  better  profiles   1.   Sundhu M, Mohapatra S, Arobelidze  S, Gundelly P, Changarath
                                                                 Vijayan AK. Infective endocarditis in a patient with celiac disease
           facilitated by double tilting discs. In 1979, the convexo-  after censtral venous catheter insertion. Cureus 2017;9:e1027.
           concave design of the Bjork-Shiley valve came under   2.   Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze
           scrutiny  as  it  was  prone  to  fractures  in  the  outflow   C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye
           strut. This resulted in the food and drug administration   F, Alla F, Duval X, Hoen B; AEPEI Study Group. Preeminence of
           withdrawing approval of the 1986, around the time our   staphylococcus aureus in infective endocarditis: a 1-year population-
                                                                 based survey. Clin Infect Dis 2012;54:1230-9.
           patient had his valve implanted. [8]               3.   Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of
                                                                 mechanical  heart valve  prostheses: clinical  aspects and surgical
           Despite advancements in valve design and refinement   management. J Am Coll Cardiol 1991;17:646-50.
           in surgical techniques, the type of valve implantation   4.   Yaminisharif  A, Alemzadeh-Ansari  MJ, Ahmadi  SH. Prosthetic
                                                                 tricuspid valve thrombosis: three case reports and literature review. J
           (mechanical versus bioprosthesis) remains a dilemma   Tehran Heart Cent 2012;7:147-55.
           among  surgeons  in  all  4  valves  positions.  Although,   5.   Betancur-Gutiérrez  A, Bayón-Fernández  J, García-Rodríguez
           patient autonomy dictates that they be given priority   MÁ, García-Egido  A, Garrote-Coloma  C, Fernández-Vázquez  F.
           to  choose the  type of  valve,  a  surgeons  input  is  of   Thrombosis of a mechanical tricuspid valve prosthesis resolved with
           paramount importance. The evolving technology has   6.   fibrinolysis. Rev Esp Cardiol (Engl Ed) 2014;67:1064-6.
                                                                 Joint Task Force on the Management of Valvular Heart Disease of
           influenced  the  guidelines  with  rapid  amendments   the European Society of Cardiology (ESC); European Association for
           and new published editions. Newer generations of      Cardio-Thoracic Surgery (EACTS); Vahanian A, Alfieri O, Andreotti
           mechanical  valves  with  better  performance  with   F, Antunes MJ, Barón-Esquivias G, Baumgartner  H, Borger MA,
           regards to amplitude and duration of regional backflow   Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P,
                                                                 Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K,
           velocities across the mechanical valve as the main    Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala
           culprit for thrombosis are currently available.  DOACs   M. Guidelines on the management of valvular heart disease (version
                                                  [9]
                           Vessel Plus ¦ Volume 1 ¦ September 26, 2017                                    153
   155   156   157   158   159   160   161   162   163   164   165